Status:

RECRUITING

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Lead Sponsor:

Bluejay Therapeutics, Inc.

Conditions:

Chronic Hepatitis D Infection

Eligibility:

All Genders

18-99 years

Phase:

PHASE3

Brief Summary

This is a Phase 3, global, randomized, open-label, multicenter, trial evaluating brelovitug (BJT-778) vs bulevirtide for the treatment of chronic hepatitis delta infection (CHD). The main goal of this...

Detailed Description

Study consists of 2 arms. Approximately 172 participants will be randomized 3:1 to one of the following treatment arms: Arm 1: Participants will receive brelovitug 300 mg subcutaneously once weekly f...

Eligibility Criteria

Inclusion

  • Key
  • Willing and able to provide written informed consent
  • Chronic HDV infection
  • HDV RNA \>500 IU/mL at Screening
  • ALT \>ULN at Screening
  • Willing to take or already taking HBV neucleos(t)ide therapy.
  • Key

Exclusion

  • Pregnant or nursing females
  • Unwilling to comply with contraception requirements during the study
  • Difficulty with blood collection and/or poor venous access for the purposes of phlebotomy
  • Clinical hepatic decompensation (i.e., ascites, encephalopathy variceal hemorrhage).
  • Solid organ or bone marrow transplantation
  • Presence of other liver disease(s) (non-HBV/HDV), such as nonalcoholic steatohepatitis (NASH), alcohol associated hepatitis, cholestatic liver disease, hepatocellular carcinoma.
  • Note - Other protocol-defined Inclusion/Exclusion criteria apply.

Key Trial Info

Start Date :

August 27 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2029

Estimated Enrollment :

172 Patients enrolled

Trial Details

Trial ID

NCT07200908

Start Date

August 27 2025

End Date

September 30 2029

Last Update

December 22 2025

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

Medical University of Graz

Graz, Austria, 8036

2

Fakultni Nemocnice Brno

Brno, Brno, Czechia, 62500

3

Fakultni Nemocnice Hradec Kralove

Hradec Králové, Hradec Králové, Czechia, 500 03

4

Institute For Clinical And Experimental Medicine

Prague, Prague, Czechia, 140 00